Previous Article | Next Article ![]()
Infect. Immun., 06 1997, 2218-2224, Vol 65, No. 6
ME Bauer and RA Welch
Several genes involved in the lipopolysaccharide (LPS) biosynthetic pathway
have been shown to affect the expression or activity of Escherichia coli
hemolysin (Hly), a secreted cytotoxin that is the prototype of the RTX
family of toxins. To further study this relationship, E. coli K-12 strains
harboring mutations in the LPS biosynthetic genes rfaS, rfaQ, rfaJ, rfaP,
and rfaC were transformed with a recombinant plasmid harboring the hlyCABD
operon and examined for their effects on extracellular expression and
hemolytic activity. A mutation in rfaC that affected both extracellular
expression and activity of Hly was studied in greater detail. This mutation
led to a growth-phase-dependent decrease up to 16-fold in the steady-state
level of extracellular HlyA, although transcription and secretion of HlyA
were decreased no more than 2-fold. Specific hemolytic activity in toxin
produced from the rfaC mutant strain was significantly reduced, in a
growth-phase-dependent manner. With the rfaC gene supplied in trans, both
the decreased expression and activity of Hly were restored to wild-type
levels. Hly from the rfaC mutant strain exhibited much slower kinetics of
hemolysis, a more rapid rate of decay of activity, and greater formation of
apparently inactive HlyA-containing aggregates in culture supernatants than
was exhibited in the wild-type strain. A model is proposed for a physical
interaction between LPS and Hly in which LPS with intact inner core
participates in forming or maintaining an active conformation of Hly and
helps to protect it from aggregation or degradation.
Copyright © 1997, American Society for Microbiology
Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, 53706, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|